Imparting antimicrobial and anti-adhesive properties to polysulfone membranes through modification with silver nanoparticles and polyelectrolyte multilayers.

The antimicrobial and bacterial anti-adhesive properties of polysulfone (PSU) membranes modified with silver nanoparticles (AgNPs) and polyelectrolyte multilayers (PEMs) composed of poly(allylamine hydrochloride) and poly(acrylic acid) were investigated. The membranes' antimicrobial properties were evaluated using a colony forming unit (CFU) enumeration method, while the anti-adhesive properties of the membranes were examined using a direct microscopy observation membrane filtration system. The AgNP mass loading required for the inhibition of bacterial growth on the AgNP/PEM-modified membranes was significantly lower than the AgNP loadings reported in other studies for membranes with the nanoparticles dispersed within the membrane matrix. The immobilization of AgNPs on the membrane surface maximized the opportunities for bacteria-nanoparticle contact, which allowed for effective bacteria inactivation. Furthermore, in comparison to unmodified PSU membranes, the bacterial deposition kinetics on all the modified membranes were reduced by ca. 50% and the bacterial removal efficiencies were significantly increased from close to 0% to as high as over 90%. Three-cycle filtration and rinsing experiments were also performed to evaluate the effectiveness of the surface modification over an extended time period of use.

A fluorescent assay suitable for inhibitor screening and vanin tissue quantification.

Vanin-1 is a pantetheinase that catalyzes the hydrolysis of pantetheine to produce pantothenic acid (vitamin B5) and cysteamine. Reported here is a highly sensitive fluorescent assay using a novel fluorescently labeled pantothenate derivative. The assay has been used for characterization of a soluble version of human vanin-1 recombinant protein, identification and characterization of hits from high-throughput screening (HTS), and quantification of vanin pantothenase activity in cell lines and tissues. Under optimized assay conditions, we quantified vanin pantothenase activity in tissue lysate and found low activity in lung and liver but high activity in kidney. We demonstrated that the purified recombinant vanin-1 consisting of the extracellular portion without the glycosylphosphatidylinositol (GPI) linker was highly active with an apparent K(m) of 28 microM for pantothenate-7-amino-4-methylcoumarin (pantothenate-AMC), which was converted to pantothenic acid and AMC based on liquid chromatography-mass spectrometry (LC-MS) analysis. The assay also performed well in a 384-well microplate format under initial rate conditions (10% conversion) with a signal-to-background ratio (S/B) of 7 and a Z factor of 0.75. Preliminary screening of a library of 1280 pharmaceutically active compounds identified inhibitors with novel chemical scaffolds. This assay will be a powerful tool for target validation and drug lead identification and characterization.